[1] |
WHO. Coronavirus(COVID-19) dashboard[EB/OL]. (2021-12-13)[2021-12-13]. .
|
[2] |
WHO. Tracking SARS-CoV-2 variants[EB/OL]. (2021-12-06)[2021-12-09]. .
|
[3] |
WHO. Classification of Omicron(B.1.1.529):SARS-CoV-2 variant of concern[EB/OL]. (2021-11-26)[2021-12-09]. .
|
[4] |
天津市卫生健康委员会. 天津从入境人员中检出新冠病毒奥密克戎变异株,为中国内地首次检出[EB/OL]. (2021-12-14)[2021-12-14]. .
|
[5] |
香港特别行政区政府卫生署. 卫生防护中心调查新增六宗2019冠状病毒病确诊个案及汇报输入个案12388及12404调查进展[EB/OL]. (2021-11-25)[2021-12-09]. .
|
[6] |
GU H, KRISHNAN P, NG D Y M,et al. Probable transmission of SARS-CoV-2 Omicron variant in Quarantine Hotel,Hong Kong,China,November 2021[J]. Emerg Infect Dis,2021,28(2):212422. DOI:10.3201/eid2802.212422.
|
[7] |
国家卫生健康委员会办公厅,国家中医药管理局办公室. 新型冠状病毒肺炎诊疗方案(试行第八版)[EB/OL]. (2020-08-18)[2021-12-09]. .
|
[8] |
CHAN J F, KOK K H, ZHU Z,et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan[J]. Emerg Microbes Infec,2020,9(1):221-236. DOI:10.1080/22221751.2020.1719902.
|
[9] |
GIOVANETTI M, BENEDETTI F, CAMPISI G,et al. Evolution patterns of SARS-CoV-2:snapshot on its genome variants[J]. Biochem Biophys Res Commun,2021,538(10):88-91. DOI:10.1016/j.bbrc.2020.10.102.
|
[10] |
GeneTex. SARS-CoV-2 Omicron变体的突变位点[EB/OL].(2021-11-29)[2021-12-09]. .
|
[11] |
CALLAWAY E. Heavily mutated Omicron variant puts scientists on alert[J]. Nature,2021,600(7887):21. DOI:10.1038/d41586-021-03552-w.
|
[12] |
CHEN J H,WANG R,GILBY N B,et al. Omicron(B.1.1.529):infectivity,vaccine breakthrough,and antibody resistance[EB/OL]. (2021-12-01)[2021-12-09]. .
|
[13] |
KUPFERSCHMIDT K. Where did 'weird' Omicron come from[J]. Science,2021,374(6572):1179. DOI:10.1126/science.acx9754.
|
[14] |
KARIM F,MOOSA M,GOSNELL B,et al. Persistent SARS-CoV-2 infection and intra-host evolution in association with advanced HIV infection[EB/OL]. (2021-06-04)[2021-12-09]. .
|
[15] |
WHO. South Africa HIV country profile 2021[EB/OL]. (2021-12-01)[2021-12-09]. .
|
[16] |
KARIM F,GAZY I,CELE S,et al. HIV status alters disease severity and immune cell responses in beta variant SARS-CoV-2 infection wave[EB/OL]. (2021-09-05)[2021-12-09]. .
|
[17] |
CHANDLER J C, BEVINS S N, ELLIS J W,et al. SARS-CoV-2 exposure in wild white-tailed deer(Odocoileus virginianus)[J]. Proc Natl Acad Sci U S A,2021,118(47):e2114828118. DOI:10.1101/2021.07.29.454326.
|
[18] |
ABBASI J. Omicron has reached the US:here's what infectious disease experts know about the variant[EB/OL]. (2021-12-06)[2021-12-09]. .
|
[19] |
CALLAWAY E, LEDFORD H. How bad is Omicron? What scientists know so far[J]. Nature,2021,600(7888):197-199. DOI:10.1038/d41586-021-03614-z.
|
[20] |
Chelsea News. The Omicron factor[EB/OL]. (2021-12-06)[2021-12-09]. .
|
[21] |
Metaculus. Estimated R0 of Omicron variant[EB/OL]. (2021-11-27)[2021-12-09]. .
|
[22] |
Our World in Data. Daily new confirmed COVID-19 cases[EB/OL]. (2021-12-09)[2021-12-09]. .
|
[23] |
China Media Grand Mishmash. Omicron variant 37.5% more infectious than Delta[EB/OL]. (2021-11-30)[2021-12-09]. .
|
[24] |
Republicworld. Omicron scare:Israeli health chiefs claim those vaccinated in last 6 months are protected[EB/OL]. (2021-12-01)[2021-12-09]. .
|
[25] |
PULLIAM J R C,VAN SCHALKWYK C,GOVENDER N,et al. Increased risk of SARS-CoV-2 reinfection associated with emergence of the Omicron variant in South Africa[EB/OL]. (2021-12-02)[2021-12-09]. .
|
[26] |
Cananli ANSA. Prima foto di Omicron da gruppo di ricerca Bambino Gesu'[EB/OL]. (2021-11-27)[2021-12-09]. .
|
[27] |
QIN S, CUI M, SUN S,et al. Genome characterization and potential risk assessment of the novel SARS-CoV-2 variant Omicron(B.1.1.529)[J]. Zoonoses,2021. [Epub ahead of print]. DOI:10.15212/ZOONOSES-2021-0024.
|
[28] |
ALI F, KASRY A, AMIN M. The new SARS-CoV-2 strain shows a stronger binding affinity to ACE2 due to N501Y mutant[J]. Med Drug Discov,2021,10:100086.
|
[29] |
WANG W B, LIANG Y, JIN Y Q,et al. E484K mutation in SARS-CoV-2 RBD enhances binding affinity with hACE2 but reduces interactions with neutralizing antibodies and nanobodies:binding free energy calculation studies[J]. J Mol Graph Model,2021,109:108035. DOI:10.1016/j.jmgm.2021.108035.
|
[30] |
RANI P R, IMRAN M, LAKSHMI J V,et al. Symptomatic reinfection of SARS-CoV-2 with spike protein variant N440K associated with immune escape[J]. J Med Virol,2021,93(7):4163-4165. DOI:10.31219/osf.io/7gk69.
|
[31] |
CHAN Y A, ZHAN S H. The emergence of the spike furin cleavage site in SARS-CoV-2[J]. Mol Biol Evol,2021. [Epub ahead of print]. DOI:10.1093/molbev/msab327.
|
[32] |
COLSON P, LEVASSEUR A, DELERCE J,et al. Spreading of a new SARS-CoV-2 N501Y spike variant in a new lineage[J]. Clin Microbiol Infect,2021,27(9):1352.e1-5. D
|
[33] |
MOHAMMAD A, ABUBAKER J, AL-MULLA F. Structural modelling of SARS-CoV-2 alpha variant(B.1.1.7) suggests enhanced furin binding and infectivity[J]. Virus Res,2021,303:198522.
|
[34] |
WU H, XING N, MENG K,et al. Nucleocapsid mutations R203K/G204R increase the infectivity,fitness,and virulence of SARS-CoV-2[J]. Cell Host Microbe,2021,29(12):1788-1801.
|
[35] |
DYER O. Covid-19:South Africa's surge in cases deepens alarm over omicron variant[J]. BMJ,2021,375:n3013.
|
[36] |
WHO. Weekly epidemiological update on COVID-19:7 December 2021[EB/OL]. (2021-12-07)[2021-12-09]. .
|
[37] |
European Centre for Disease Prevention and Control. Epidemiological update:Omicron variant of concern(VOC):data as of 7 December 2021(12.00)[EB/OL]. (2021-12-07)[2021-12-09]. .
|
[38] |
CDC. Omicron variant:what you need to know[EB/OL]. (2021-12-09)[2021-12-09]. .
|
[39] |
Eminetra. WHO:most Omicron cases are "mild" or asymptomatic,and existing vaccines need to provide protection[EB/OL]. (2021-12-03)[2021-12-09]. .
|
[40] |
SAMRS. Tshwane District Omicron variant patient profile:early features[EB/OL]. (2021-12-04)[2021-12-09]. .
|
[41] |
GAO S J, GUO H, LUO G. Omicron variant(B.1.1.529) of SARS-CoV-2,a global urgent public health alert[J]. J Med Virol,2022,94(1). DOI:10.1002/jmv.27491.
|
[42] |
CELE S,JACKSON L. SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection[EB/OL]. (2021-12-07)[2021-12-09]. .
|
[43] |
CNBC. Pfizer and BioNTech say booster dose provides high level of protection against omicron variant in initial lab study[EB/OL]. (2021-12-08)[2021-12-09]. .
|
[44] |
NBC. Moderna says an omicron variant vaccine could be ready in early 2022[EB/OL]. (2021-11-28)[2021-12-09]. .
|
[45] |
Australian Government Department of Health. Additional border security measures to protect Australians from the new 'Omicron' COVID-19 variant[EB/OL]. (2021-11-27) [2021-12-09]. .
|
[46] |
Public Health Agency of Canada. Government of Canada introduces additional measures to address COVID-19 Omicron variant of concern[EB/OL]. (2021-11-30)[2021-12-09]. .
|
[47] |
国家卫生健康委. 关于奥密克戎,国家卫生健康委权威解答来了[EB/OL]. (2021-11-29) [2021-12-09]. .
|